Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Well, the first step is diagnosis. We have ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease (CKD). Ziltivekimab, a novel anti-IL-6 ligand antibody, improves ...

During the median follow-up of 2.5 years, 2887 and 429 composite anemia outcomes were recorded in patients receiving SGLT2 inhibitors and GLP-1 RAs, respectively. The incidence rate of composite ...

Authors of a recent review explored the complex relationship between CKD, COVID-19, and anemia and offered practice points based on clinical experience. Patients with chronic kidney disease (CKD) ...

We observed that anemia and chronic kidney disease are two frequent conditions among stroke patients. Anemia was independently associated with a decreased one-year survival. Although GFR was ...

Treatment with vadadustat was noninferior to darbepoetin alfa in correcting and maintaining Hb levels in adults with incident dialysis-dependent CKD. The Food and Drug Administration (FDA) has ...

Chronic kidney disease (CKD) is frequently complicated by anaemia, predominantly due to an inadequate production of erythropoietin combined with disruptions in iron metabolism and chronic inflammation ...

U.S. Erythropoietin Drugs Market size was USD 4.02 Billion in 2025 and is expected to reach USD 6.18 Billion by 2035 owing to the strong dialysis infrastructure and increasing anemia treatment demand.

GREENFIELD, Ind.--(BUSINESS WIRE)-- Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzin™-CA1 (molidustat oral suspension), conditionally approved by ...